Viola Klück
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Gout, Hyperuricemia, Uric Acid 7
-
- Inflammasome and immune disorders 6
- Co-authors
- Leo A. B. Joosten (13 shared papers)Tania O. Crișan (8 shared papers)Radu A. Popp (3 shared papers)Charles A. Dinarello (4 shared papers)Maartje C. P. Cleophas (3 shared papers)Isak W. Tengesdal (2 shared papers)Tim Jansen (4 shared papers)Ruiqi Liu (2 shared papers)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Cytokine (2 papers)Arthritis Research & Therapy (2 papers)The Lancet Rheumatology (1 paper)Immunology (1 paper)
- Partner nations
- NetherlandsRomaniaUnited States
In The Last Decade
Viola Klück
16 papers receiving 621 citations
Viola Klück's Hit Papers
Peers
Comparison fields: 5 of 63
- Nephrology 284
- Biological Psychiatry 21
- Immunology 161
- Molecular Biology 322
- Rheumatology 56
Countries citing papers authored by Viola Klück
This map shows the geographic impact of Viola Klück's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viola Klück with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viola Klück more than expected).
Fields of papers citing papers by Viola Klück
This network shows the impact of papers produced by Viola Klück. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viola Klück. The network helps show where Viola Klück may publish in the future.
Co-authors
The 25 scholars most cited alongside Viola Klück, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial Hit paper breakdown → | 2020 | 213 |
| 2 | 2019 | 194 | |
| 3 | 2020 | 57 | |
| 4 | 2018 | 45 | |
| 5 | 2019 | 38 | |
| 6 | 2021 | 31 | |
| 7 | 2019 | 16 | |
| 8 | 2024 | 13 | |
| 9 | 2023 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2023 | 3 | |
| 12 | 2024 | 3 | |
| 13 | 2019 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2024 | 1 |
About Viola Klück
Viola Klück is a scholar working on Nephrology, Molecular Biology, Immunology, Infectious Diseases and Small Animals, having authored 16 papers that have together received 631 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (7 papers), Inflammasome and immune disorders (6 papers), Immune Cell Function and Interaction (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Adipose Tissue and Metabolism (1 paper), Urticaria and Related Conditions (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Nephrology (284 citations), Biological Psychiatry (21 citations), Immunology (161 citations), Molecular Biology (322 citations) and Rheumatology (56 citations). Viola Klück has collaborated with scholars based in Netherlands, Romania and United States. Frequent co-authors include Leo A. B. Joosten, Tania O. Crișan, Radu A. Popp, Charles A. Dinarello, Maartje C. P. Cleophas, Isak W. Tengesdal, Tim Jansen, Ruiqi Liu, M. Efdé and M. Janssen. Their work appears in journals such as Annals of the Rheumatic Diseases, Cytokine, Arthritis Research & Therapy, The Lancet Rheumatology and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.